Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03019822Phase 1Completed
Phase 1, randomised, double-blind trial of Lysergide, midomafetamine and amphetamine, sponsored by University Hospital Basel. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03019822.